| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |